SCHEMBL29379293

SCHEMBL29379293

Cc1ccc(S(F)(F)(F)(F)F)cc1[N+](=O)[O-]

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 6/20 0.56
ALDH1A1 P00352 4/20 0.56
CYP3A4 P08684 2/20 0.56
RECQL P46063 1/20 0.56
HSD17B10 Q99714 1/20 0.48
CES2 O00748 1/20 0.46
CES1 P23141 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.43
MAPT P10636 2/20 0.43
MEN1 O00255 1/20 0.43
NPC1 O15118 1/20 0.43
LMNA P02545 1/20 0.43
MAPK1 P28482 1/20 0.43
RAB9A P51151 1/20 0.43
KMT2A Q03164 1/20 0.43
CRHBP P24387 1/20 0.43
CRHR2 Q13324 1/20 0.43
MCOLN3 Q8TDD5 1/20 0.43
TDP1 Q9NUW8 2/20 0.42
PPIA P62937 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9998849 1.00 TSHR (0.56) TSHRALDH1A1CYP3A4RECQLHSD17B10
SCHEMBL30072759 0.87 MAPT (0.51) TSHRALDH1A1CYP3A4RECQLHSD17B10
SCHEMBL18956859 0.87 MAPT (0.51) TSHRALDH1A1CYP3A4RECQLHSD17B10
SCHEMBL9998742 0.80 TDP1 (0.48) TSHRALDH1A1CYP3A4RECQLHSD17B10
SCHEMBL8031393 0.79 ALDH1A1 (0.46) ALDH1A1CYP3A4MAPTMEN1LMNA
SCHEMBL21885660 0.79 GPR35 (0.56) TSHRALDH1A1CYP3A4HSD17B10SMN1; SMN2
SCHEMBL18607548 0.79 VCAM1 (0.51) TSHRMAPTMAPK1TDP1
SCHEMBL8041974 0.79 MAPT (0.58) TSHRALDH1A1CYP3A4RECQLMAPT
SCHEMBL18607708 0.79 ALDH1A1 (0.51) TSHRALDH1A1CYP3A4SMN1; SMN2MAPT
SCHEMBL14676672 0.79 HCAR3 (0.54) ALDH1A1RECQLSMN1; SMN2MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114042070-A Compounds as neuronal histamine receptor-3 antagonists and uses thereof 凯瑞康宁生物工程(武汉)有限公司 2022-02-15 CN disclosed